Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Montes Archimedes Acquisition shares have lost about 2.9% since the beginning of the year versus the S&P 500's gain of 8.6%. What's Next for Montes Archimedes Acquisition? While Montes Archimedes Acquisition has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current c ...